ProfileGDS4132 / 219571_s_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 36% 34% 36% 36% 37% 32% 33% 35% 39% 33% 41% 43% 40% 55% 40% 50% 40% 48% 50% 40% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10191.015936
GSM201543Muscle PCOS pioglitazone 12175.693334
GSM201544Muscle PCOS pioglitazone 16194.106836
GSM201545Muscle PCOS pioglitazone 20198.433336
GSM201829Muscle PCOS pioglitazone 231101.50637
GSM201830Muscle PCOS pioglitazon 25183.570432
GSM201831Muscle PCOS pioglitazone 27181.810133
GSM201832Muscle PCOS pioglitazone 3189.311235
GSM201833Muscle PCOS pioglitazone 4195.44339
GSM201834Muscle PCOS pioglitazone 8181.048833
GSM201835Muscle PCOS after pioglitazone 10292.566841
GSM201836Muscle PCOS after pioglitazone 122101.06143
GSM201837Muscle PCOS after pioglitazone 16288.950840
GSM201838Muscle PCOS after pioglitazone 202139.5655
GSM201839Muscle PCOS after pioglitazone 23296.907340
GSM201840Muscle PCOS after pioglitazone 252130.83450
GSM201841Muscle PCOS after pioglitazone 27289.039940
GSM201842Muscle PCOS after pioglitazone 32105.75448
GSM201843Muscle PCOS after pioglitazone 42127.7550
GSM201844Muscle PCOS after pioglitazone 8297.299240